Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Weiao Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the research, development, and large-scale manufacturing of chemical medicines. Based in Chengdu, the company focuses on therapeutic areas such as cardiovascular health, gastroenterology, and anti-infectives. Its product portfolio includes widely used treatments like trimetazidine for angina and omeprazole for gastric conditions. Sichuan Weiao operates advanced GMP-certified facilities and is recognized for its commitment to quality and innovation in the domestic market. The company serves as a key manufacturing hub within its corporate group, supplying both domestic and international healthcare providers. It is recognized as a high-tech enterprise in Sichuan Province, contributing significantly to the regional pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Weiao Pharmaceutical.